Emerg Infect Dis. 2021 Mar;27(3):681-686. doi: 10.3201/eid2703.203456. Epub 2020 Nov 19.
The coronavirus disease (COVID-19) pandemic has had unprecedented negative effects on global health and economies, drawing attention and resources from many other public health services. To minimize negative effects, the parallels, lessons, and resources from existing public health programs need to be identified and used. Often underappreciated synergies relating to COVID-19 are with tuberculosis (TB). COVID-19 and TB share commonalities in transmission and public health response: case finding, contact identification, and evaluation. Data supporting interventions for either disease are, understandably, vastly different, given the diseases' different histories. However, many of the evolving issues affecting these diseases are increasingly similar. As previously done for TB, all aspects of congregate investigations and preventive and therapeutic measures for COVID-19 must be prospectively studied for optimal evidence-based interventions. New attention garnered by the pandemic can ensure that knowledge and investment can benefit both COVID-19 response and traditional public health programs such as TB programs.
冠状病毒病(COVID-19)大流行对全球健康和经济产生了前所未有的负面影响,从许多其他公共卫生服务中吸引了关注和资源。为了将负面影响降到最低,需要确定并利用现有公共卫生计划的相似之处、经验教训和资源。与结核病(TB)相比,COVID-19 往往被低估了协同作用。COVID-19 和 TB 在传播和公共卫生应对方面具有共同之处:病例发现、接触者识别和评估。由于疾病的历史不同,支持干预措施的数据差异很大,对于这两种疾病的数据支持干预措施差异很大。然而,影响这些疾病的许多不断发展的问题越来越相似。以前针对结核病所做的那样,必须前瞻性地研究 COVID-19 的聚集性调查和预防及治疗措施的各个方面,以制定最佳的循证干预措施。大流行引起的新关注可以确保知识和投资既可以使 COVID-19 应对措施受益,也可以使传统的公共卫生计划(如结核病计划)受益。